While over 75% of BRCA1-mutated and about 50% of BRCA2-mutated breast cancers exhibit a TNBC phenotype, only 10–20% of all TNBC cases are due to inherited (germline) BRCA mutations. This evidence concerns the gene BRCA1 and breast cancer.